IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Svennilson Peter

Q1 2019 Holdings

Filed 2019-05-08 | 9 holdings | $44.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcus Biosciences Inc.(RCUS)COM03969F109$44.2M3,540,85099.7%
Constellation Pharmceticls I(CNST)COM210373106$63.4K4,677,9390.1%
Gritstone Oncology Inc.(2JQ)COM39868T105$41.3K3,102,9340.1%
Immune Design Corp.COM45252L103$38.9K6,642,9420.1%